These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 3897284)
1. Secretion of an articular cartilage proteoglycan-degrading enzyme activity by murine T lymphocytes in vitro. Kammer GM; Sapolsky AI; Malemud CJ J Clin Invest; 1985 Aug; 76(2):395-402. PubMed ID: 3897284 [TBL] [Abstract][Full Text] [Related]
2. Human mononuclear cell factors mediate cartilage matrix degradation through chondrocyte activation. Jasin HE; Dingle JT J Clin Invest; 1981 Sep; 68(3):571-81. PubMed ID: 7276159 [TBL] [Abstract][Full Text] [Related]
3. Spontaneous secretion of a proteoglycan releasing factor by mononuclear cells in juvenile arthritis. Silverman ED; Smith RL; Schurman DJ; Miller JJ J Rheumatol; 1987 Jun; 14(3):540-7. PubMed ID: 3498038 [TBL] [Abstract][Full Text] [Related]
4. Effects of growth factors and interleukin-1 alpha on proteoglycan and type II collagen turnover in bovine nasal and articular chondrocyte pellet cultures. Xu C; Oyajobi BO; Frazer A; Kozaci LD; Russell RG; Hollander AP Endocrinology; 1996 Aug; 137(8):3557-65. PubMed ID: 8754787 [TBL] [Abstract][Full Text] [Related]
5. Degradation of cartilage proteoglycan by human leukocyte granule neutral proteases--a model of joint injury. II. Degradation of isolated bovine nasal cartilage proteoglycan. Keiser H; Greenwald RA; Feinstein G; Janoff A J Clin Invest; 1976 Mar; 57(3):625-32. PubMed ID: 129483 [TBL] [Abstract][Full Text] [Related]
6. A tissue-culture model of cartilage breakdown in rheumatoid arthritis. Quantitative aspects of proteoglycan release. Steinberg J; Sledge CB; Noble J; Stirrat CR Biochem J; 1979 May; 180(2):403-12. PubMed ID: 486116 [TBL] [Abstract][Full Text] [Related]
7. Intact proteoglycan is a polyclonal activator of murine B-lymphocytes. Siegel JN; Malemud CJ; Kammer GM Immunol Lett; 1987 Jun; 15(2):127-32. PubMed ID: 3497871 [TBL] [Abstract][Full Text] [Related]
8. Metalloproteases of human articular cartilage that digest cartilage proteoglycan at neutral and acid pH. Sapolsky AI; Keiser H; Howell DS; Woessner JF J Clin Invest; 1976 Oct; 58(4):1030-41. PubMed ID: 9425 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 stimulates the secretion of proteoglycan- and collagen-degrading proteases by rabbit articular chondrocytes. Pasternak RD; Hubbs SJ; Caccese RG; Marks RL; Conaty JM; DiPasquale G Clin Immunol Immunopathol; 1986 Dec; 41(3):351-67. PubMed ID: 3536222 [TBL] [Abstract][Full Text] [Related]
10. Studies on the release of proteolytic enzymes during synovium-induced cartilage breakdown in vitro and the actions of anti-inflammatory drugs. Crossley MJ; Hunneyball IM Biochem Pharmacol; 1984 Apr; 33(8):1263-71. PubMed ID: 6324820 [TBL] [Abstract][Full Text] [Related]
11. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761 [TBL] [Abstract][Full Text] [Related]
13. Divergent effects of suramin on in vitro and in vivo assays of cartilage degradation. Ackerman NR; Jubb S; Trimble B; Marlowe S; Miram L; Maloney P J Pharmacol Exp Ther; 1983 May; 225(2):243-50. PubMed ID: 6341539 [TBL] [Abstract][Full Text] [Related]
14. Proteoglycan- and collagen-degrading enzymes from human interleukin 1-stimulated chondrocytes from several species: proteoglycanase and collagenase inhibitors as potentially new disease-modifying antiarthritic agents. DiPasquale G; Caccese R; Pasternak R; Conaty J; Hubbs S; Perry K Proc Soc Exp Biol Med; 1986 Nov; 183(2):262-7. PubMed ID: 3020566 [TBL] [Abstract][Full Text] [Related]
15. Human articular cartilage secretes characteristic metal dependent proteinases upon stimulation by mononuclear cell factor. Campbell IK; Golds EE; Mort JS; Roughley PJ J Rheumatol; 1986 Feb; 13(1):20-7. PubMed ID: 3517323 [TBL] [Abstract][Full Text] [Related]
16. The in vitro cell culture age and cell density of articular chondrocytes alter sulfated-proteoglycan biosynthesis. Malemud CJ; Papay RS J Cell Physiol; 1984 Dec; 121(3):558-68. PubMed ID: 6438120 [TBL] [Abstract][Full Text] [Related]
17. Rapid degradation of articular cartilage proteoglycan by neutrophils: comparison with macrophages and synovial fibroblasts. Halliday DA; Clemente G; Rathjen DA; Ferrante A Inflamm Res; 2000 Sep; 49(9):441-4. PubMed ID: 11071117 [TBL] [Abstract][Full Text] [Related]
18. Lymphocyte-macrophage-fibroblast co-operation in the inflammatory degradation of cartilage and connective tissue. Vaes G; Huybrechts-Godin G; Hauser P Agents Actions Suppl; 1980; 7():100-8. PubMed ID: 6264765 [TBL] [Abstract][Full Text] [Related]
19. Cartilage proteoglycan degradation by a mouse transformed macrophage cell line is mediated by macrophage metalloelastase. Janusz MJ; Hare M; Durham SL; Potempa J; McGraw W; Pike R; Travis J; Shapiro SD Inflamm Res; 1999 May; 48(5):280-8. PubMed ID: 10391117 [TBL] [Abstract][Full Text] [Related]
20. The properties of the neutral proteinase released by primary chondrocyte cultures and its action on proteoglycan aggregate. Morales TI; Kuettner KE Biochim Biophys Acta; 1982 Jul; 705(1):92-101. PubMed ID: 7052134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]